This paper presents a description of tests carried out to compare the behaviour of five algorithms in inverse radiation therapy planning: (1) The Dynamically Penalized Likelihood (DPL), an algorithm based on statistical estimation theory; (2) an accelerated version of the same algorithm; (3) a new fast adaptive simulated annealing (ASA) algorithm; (4) a conjugate gradient method; and (5) a Newton gradient method. A three-dimensional mathematical phantom and two clinical cases have been studied in detail. The phantom consisted of a U-shaped tumour with a partially enclosed 'spinal cord'. The clinical examples were a cavernous sinus meningioma and a prostate case. The algorithms have been tested in carefully selected and controlled conditions so as to ensure fairness in the assessment of results. It has been found that all five methods can yield relatively similar optimizations, except when a very demanding optimization is carried out. For the easier cases, the differences are principally in robustness, ease of use and optimization speed. In the more demanding case, there are significant differences in the resulting dose distributions. The accelerated DPL emerges as possibly the algorithm of choice for clinical practice. An appendix describes the differences in behaviour between the new ASA method and the one based on a patent by the Nomos Corporation.
Introduction
In November 1997, the first author of this paper published a description of the Dynamically Penalized Likelihood (DPL) method of inverse therapy planning (Llacer 1997) . It responded to the need, already pointed out by Powlis et al (1989) and by Bortfeld et al (1990) , to treat voxels corresponding to organs at risk (OAR) in a manner different from those of the planning target volume (PTV) by specifying for the former a desired maximum dose, for example, but otherwise allowing those voxels complete freedom to receive any dose lower than that maximum. Since that time, the algorithms of Bortfeld et al (1990 Bortfeld et al ( , 1997 and Spirou and Chui (1998) have become perhaps the two most recognized analytic (non-stochastic) inversion methods being used in treatment planning. Since its first publication, the DPL has evolved considerably and we feel that it is now ready to be compared to those two algorithms and to a suitable simulated annealing method.
It is recognized that it is practically impossible to set up the conjugate gradient (CG) method of Spirou and Chui and the Newton gradient (NG) method of Bortfeld et al in the same manner as in the Memorial Sloan-Kettering Cancer Center and in DKFZ-Heidelberg, respectively, even with the extensive help that has been received from these authors. For that reason, this work has been specifically directed to test the actual mechanisms for solving the inverse problem in a set of conditions that is as close as possible to the conditions under which the DPL inversion engine is operating successfully in the BrainLAB's Intensity Modulated Radiation Therapy/Surgery (IMRT/IMRS) software package (BrainSCAN 2001) . These conditions can be summarized as follows:
1. The algorithm has to be fast enough so that optimizations using dose matrices including complete scattering effects can be carried out. In this manner, a verification step through a Federal Drug Administration (USA) approved algorithm will not produce any significant differences between what was expected and the actual outcome of an optimization. 2. The oncologist has to be able to specify the desired OAR dose volume histograms (DVHs) by defining a number of points in the corresponding DVH graphs. OAR voxels may receive lower doses than the oncologist's specifications. 3. The specification of DVHs for the PTV has been considered an over-constraint on the problem. Indeed, a specified set of DVH curves for the OARs and for the PTV is likely to be, to a smaller or larger extent, contradictory. Instead, the algorithm has to provide the most 'compact' PTV DVH that is compatible with the requirements placed on the OARs. That includes, of course, the smallest possible under-dosing of the PTV voxels. 4. The algorithm should be able to incorporate a filtering method, or smoothing constraint, inside the optimization loop, so that the resulting beam fluences are the best possible for a certain degree of smoothness in the beam profiles to be delivered.
The simulated annealing method that appears to be in use by the Nomos Corp.,as described in their patent (Nomos Corp. 2000) , is basically out of contention for the purposes of this comparison. The use of non-analytical DVHs as target functions makes that process much slower than the new adaptive simulated annealing (ASA) algorithm to be described below, it cannot incorporate a filter inside the optimization loop and offers no apparent advantages over the ASA. The appendix will describe our implementation of the Nomos algorithm (NM) and the differences in behaviour in relation to the ASA. This paper will initially describe the five algorithms used in the detailed comparison, their specific implementation, the phantom and medical cases that have been studied, give results in terms of quantitative and qualitative characteristics of the optimizations, discuss some particularities of the different algorithms and draw some conclusions.
Algorithms

DPL and accelerated DPL algorithms
The DPL is a variant of the maximum likelihood estimator (MLE) method of statistical parameter estimation. The basic foundation for the use of the MLE in treatment planning optimization was described in Llacer (1997) and the current form of the DPL has been given in Llacer (2000) . The relationship between the MLE-DPL method and a minimum least squares solution will be shown here and the final iterative formula, with the addition of filtering inside the optimization loop, will be given.
It will be useful to start with a description of the target function for the MLE, first derived for PET image reconstruction by Shepp and Vardi (1982) , adapted to our problem. The joint probability of obtaining a vector of doses d in the voxels of a PTV, when a vector of beamlet fluences a deposits energy in those voxels is given by
where h i = j F ij a j is the mean dose received by voxel i, a j is the fluence of beamlet j, i is the index for each voxel in the PTV, D is the region that includes all PTV voxels, d i the dose desired in a specific voxel of the PTV and F ij are the dose matrix elements, dose delivered by beamlet j to voxel i per unit beam fluence. Equation (1) holds strictly for the numbers of photon interactions that deposit energy in a set of voxels, which follow Poisson statistics. Note that h i is the mean of each corresponding Poisson distribution and the values of d are limited to non-negative integers in a strict interpretation of Poisson statistics. An extension to dose values that are not integers is straightforward (Vardi and Lee 1993) .
When the number of photons is very large, as is the case in radiation therapy, the Poisson distribution is almost identical to a Gaussian distribution of variance equal to its mean, except at the region near d i = 0, as there are no negative values of d i in the Poisson case and there will be a negative region in the Gaussian distribution, even if small.
It is instructive, then, to write a target formula equivalent to equation (1) for a Gaussian distribution
where, as above, h i = j F ij a j is the mean dose received by voxel i and also the variance of each Gaussian in the product. The MLE does not attempt to maximize equation (1) as a function of the parameters a i , but its logarithm
If we then look at the corresponding equation for the Gaussian case we have
Because of the slowly varying log terms, a maximization of equation (4) is closely equivalent to a minimization of its quadratic terms. It follows that a maximization of the log likelihood function of equation (3) is approximately a minimization of the quadratic differences between the desired doses in each PTV voxel and the actual dose that will be delivered, weighted by the inverse of the actual dose received. This means that the MLE method tries to satisfy better the desired doses delivered to voxels that receive lower dose than those that receive higher dose. It does that optimization process without attempting to find negative values of the beamlet weights, which have no meaning in Poisson statistics or in the physical problem that we are trying to solve. The iterative formula for the DPL algorithm, derived from the maximization of equation (3), including filtering terms is given by
where a (k) j is the fluence of beamlet j at iteration (k), S is the region that includes all OAR voxels, s i is the maximum dose desired in a specific voxel of an OAR, α is the filter parameter that controls the degree of smoothness, η ∈ N j is the neighbourhood of pencil beam j to be considered for filtering, λ η are the weight parameters for the neighbouring beam fluences,
F ij is a normalization factor and β i are weights that determine the relative importance of the conditions set for voxel i of the OAR. The filtering terms penalize solutions that yield beamlet weights that are substantially different from their neighbours.
The exponent n in the outer brackets corresponds to an acceleration parameter that must be equal to 1.0 for the DPL algorithm (DPL1) as derived from the MLE target function by the expectation-maximization algorithm (Shepp and Vardi 1982) . The accelerated form of the DPL, which will be labelled DPL2, allows an exponent n > 1.0 when derived by the successive approximation method (Hildebrandt 1974) . The convergence to a single broad maximum is assured for the DPL1 (Shepp and Vardi 1982) , while convergence of the DPL2 has not been proven theoretically and, in practice, depends on the magnitude of the acceleration exponent for a particular type of problem.
Excluding the filtering term, the correction between iterations consists of two summations, the first over the voxels in the PTVs (i ∈ D) and the second over the voxels in the OARs (i ∈ S), but only for those voxels that receive a dose h i at iteration (k) that is larger than the desired dose s i . The desired dose in the PTV is given by d i . One recognizes the form of equation (5) as belonging to an MLE iterative step, but with the number of terms in the second summation changing dynamically as required to satisfy a desired dose distribution in the OARs. The iterative function of the algorithm is, in effect, an adaptive function.
It has been demonstrated in a paper by Llacer et al (1989) that an MLE solution is equivalent to a series of iterations in which the results of an iteration formally fulfil the role of the best prior information available before the start of the next iteration. If we take the results at iteration (k) and use equation (5) to calculate the optimization at iteration (k + 1) and then permanently fix the number of terms in the second summation of equation (1), the calculation of (k + 2), (k + 3), etc would proceed as a totally normal MLE estimation which leads to a stable single maximum (Shepp and Vardi 1982) . Instead, we do not fix the number of terms in the second summation and take the results of iteration (k + 1) as prior information to calculate the results of iteration (k + 2), etc with a variable number of terms. At each one of the iterations the algorithm is provided with a starting set of beam values that is the best knowledge up to that point about the solution and it could continue with the same number of terms in the second summation to a stable maximum. A sequence of those iterations has to lead to a stable single maximum and it does.
Quadratic cost function algorithms
The CG, NG and ASA algorithms use the following quadratic cost function:
The notation is identical to that of equations (1) and (5). For the CG algorithm, the conjugate gradient functions of Numerical Recipes in C provide the framework for the iterative procedure. The gradient vector at the beginning of an iteration is calculated from equation (6) and a 'line minimization' procedure is carried out to find the point x min along that direction that leads to the lowest cost function. Following the prescription of Spirou and Chui (1998) , if any of the vector components (beamlet weights) are negative at the point of lowest cost, the magnitude of x min is decreased until all the components are positive or zero. If a component was zero in the previous iteration and has become negative in the current one, it is simply returned to zero and the computation continues with that value. Refer to Spirou and Chui (1998) and to Numerical Recipes in C (1988) for details of the conjugate gradient calculation.
For line minimization, Spirou and Chui (1998) have indicated that an exact value for x min can be obtained for a quadratic cost function without having to use the 'linmin' routine from Numerical Recipes that is more general and can be very slow. The exact solution for x min has been used for the work reported here, with considerable computation time saving over 'linmin'.
Following Bortfeld et al (1990) , the iterative formula derived from equation (6) for the NG method is
where N is the number of therapy beams (ports) used in the planning, γ is a relaxation parameter, q jj = i∈D (F ij (F ij ) 2 and T is the Hessian of the filtering matrix obtained from the last summation of the cost function. For moderate filtering, it has been possible to leave the inverse of the Hessian out of the normalization terms q jj . A more complete formulation renders the iterative function much more complex, with necessarily slower calculation of the iterative process.
In the ASA method, the cost function of equation (6) and its first partial derivatives are used to calculate the acceptability of a test change in a randomly selected beam fluence. The use of partial derivatives of the analytic cost function equation (6) greatly speeds up the solution when compared to a cost function that uses the non-analytic desired DVH curves directly. When testing whether to accept or reject a small change in a randomly selected beam weight, the magnitude and sign of that change is multiplied by the values of the first partial derivatives as a first-order approximation to the change in cost function. If that change in cost function is acceptable, the small change in beam weight is accepted. The methodology for the use of simulated annealing in inverse therapy planning is well known. Webb (1995) has given a most complete description of the method, including discussions on a series of issues that affect its performance. The ASA method is a direct application of that methodology to the cost function of equation (6), including the adaptive nature of the OAR terms. Extensive tests have been made with the adjustable algorithm parameters in order to be able to report the apparently best results obtainable in the optimization cases studied. The values of those parameters will be given below. In describing the results of the ASA method, one 'iteration' will mean one pass through all the randomly arranged dose matrix columns. The random arrangement is different for each iteration. The optimization results depend, of course, on the initial seed for the random number generator, but the effect is sufficiently small that any of the results obtained with different seeds could be reported here without affecting the conclusions.
Implementation
Specification of maximum desired OAR doses
One of the conditions that has been required of the tested algorithms is that an oncologist should be able to specify the maximum desired OAR DVHs by defining a number of points in the corresponding DVH graphs. It is then necessary to define a relationship between those DVH points and the maximum desired OAR doses s i in equations (5), (6) and (7). When there are voxels in a particular OAR that receive excessive dose, and there are too many of them, Bortfeld et al (1997) choose to apply a penalty to those voxels that receive the smallest excess dose. Spirou and Chui (1998) apply the penalty to those voxels that, when sorted in ascending order of dose received, exceed the maximum allowed volume. The procedure used for the work reported in this paper is more closely related to the latter than to the former. It is based on the observation that the OAR voxels that receive highest dose at some point in the iterative process are likely to be the voxels that will also receive the highest dose after the next iteration. The procedure can be described as follows: before an iteration, a ranking of the doses received by each voxel in an OAR is done in terms of the dose that they receive at the end of the previous iteration. The fraction of voxels that are desired to have doses between the maximum allowable dose and the next point in the DVH to the left of that maximum is selected from the ranked list starting from the maximum. The desired doses s i that will be used for the next iteration for those selected voxels will then be the doses that they received in the ranking, scaled to fit between the maximum desired dose and the dose for the first point to its left. The same procedure is used for the voxels that have to fit between the first DVH point to the left of the maximum and the second point, selecting the set of highest ranked voxels still unassigned, and so forth. The procedure is repeated after each iteration of the algorithm, as there is always some rearranging of the voxel order between iterations. The programs are set to allow up to 4 points to describe a desired DVH in a graph.
Optimization procedure
The procedure to carry out an optimization has been made identical in the DPL1, DPL2, ASA and CG methods.
1. One iteration of the MLE is carried out for the only purpose of bringing the beamlet fluences, initially set exactly to 1.0, to the proper level for the dose required in the PTV. 2. The average of the beam fluences obtained in step 1 is used as a starting point to optimize the PTV only. In this step the OARs are totally disregarded and no filtering is done. A fixed number of iterations is adequate for that purpose.
3. The beam fluences from the PTV-only optimization are used to start the full PTV and OAR optimization. The results of the PTV-only optimization are needed as a starting point for the assignment of the desired OAR doses s i in equations (5), (6) and (7). These results contain the OAR dose values that, when ranked and scaled, will be used in the first iteration of the full optimization, as described in section 3.1.
For the NG method, as suggested by Bortfeld in private communication, the PTV-only optimization is started from beamlet fluences equal to 0.0 and a relaxation factor γ = 1.0. At the end of the second iteration, the relaxation value is scaled by the ratio of the desired dose in the PTV to the average dose at the end of that second iteration. The scaled value of γ is maintained throughout the optimization.
Step 3, above, is carried out as in the other methods.
As indicated above, the ASA method has a number of internal parameters that need to be experimented with until the apparently best results are obtained. For the problems studied in this paper, the following values have been chosen:
1. Initial grain fraction, the initial relative size of change in a beamlet weight that will be tested for acceptance = 0.05. 2. Smallest grain fraction = 0.0005 at iteration 600. Grain fraction decreases linearly between the first iteration and the 600th, remaining constant after that. None of the solutions presented here have reached the 600th iteration. 3. Grain0 is the highest beamlet weight after the first MLE iteration of the PTV (step 1, above) multiplied by the grain fraction. 4. kT0, is the temperature that would cause a positive change in the cost function to be accepted with a probability of 0.02 when the highest beamlet weight changes by Grain0. 5. kT is temperature of the simulated annealing process, given by kT0/log(1 + iteration number), starting at iteration 1.
The random number generator used in the ASA optimizations is Subroutine ran2, from Numerical Recipes in C (1988) . In all the methods tested, the weights β i in equations (5), (6) and (7) have been varied between 0.1 and 10.0 for voxels corresponding to different OARs. In order to limit the number of figures and results in this paper to a reasonable value, only the results with β i = 1.0 will be given in detail. The effect of changing those parameters in the different algorithms will be discussed in the conclusions.
The acceleration exponent n of the DPL2 algorithm has been set equal to 2.0 for the PTV-only optimizations and 1.7 for the full optimizations, except when some values of β i have been above approximately 5.0, in which case n has been reduced to between 1.25 and 1.4, as required for stability.
Stopping rule
The best way to stop the iterations consistently for the five methods tested involved monitoring the normalized absolute value of the derivative of the average dose in each OAR. When all the normalized derivatives, averaged over 10 iterations, are below a certain convergence threshold, the iterative process stops. Values of the threshold as small as 0.0005 and 0.0002 have been used for the work reported here, with significant improvements in the underdosing tail of the PTV in the latter iterations. Larger values may be sufficiently good for clinical use.
The fluence map complexity (FMC)
The user-supplied filter parameter α controls the strength of the smoothing or filtering operation. Because of the different nature of the algorithms tested, the same value of the parameter does not correspond to a similar effect in the optimization by different methods. A measure of smoothness in the beam fluence profiles has been devised that has been found useful in setting the values of α in such a way that the results of different algorithms can be compared. This measure, called the fluence map complexity (FMC), can perhaps be an initial step in determining the desirability of a therapy plan for delivery by multi-leaf collimators. The FMC responds to both the differences between adjacent beam weights and the existence of some excessively large beam weights in the periphery of the field in an otherwise relatively uniform beam map.
Based on the form of the filtering terms in equations (5) and (6), an FMC has been defined by
The summation under the square root contains the same terms as the filter in the target function of the DPL. Each term goes to zero if the fluence a j is equal to its two lateral neighbours, which have λ k = 0.5 assigned to them. For a beam in the periphery, λ k of its only lateral neighbour is set to 1.0. Because of the quadratic form, a single very high fluence carries a lot of weight in the summation. The square root and the normalization by the sum of all fluences are intended to lead to numbers that are reasonable for comparisons.
Coding concerns
The algorithms have been implemented in such a manner that the high-speed processing characteristics for data in the cache of the Intel Pentium III architecture could be utilized. The advantage of that coding is felt principally in the DPL and NG algorithms that have two matrix-vector multiplications per iteration, in the calculation of the h i values of equations (5) and (7). These operations, projections of the current beam weights onto the PTV and OAR volumes, can be up to five times faster when the outer loop of the two-loop code is done over the matrix columns. In that way, all the arithmetic operations that can be carried out with one column of the dose matrix F while it is in the cache memory are completed before the processing unit calls the next column from RAM. The speed improvement is most important in large problems, because matrix-vector multiplications become dominant over all other calculations. The optimization times reported below correspond to the inversion process carried out by a single Pentium III Xeon 1GHz processor with a 256 Kbyte cache, exclusive of dose matrix calculation and disk I/O. The complete dose matrices are in RAM during inversion. Note that the backprojection operation of the errors in equations (5) and (7), which is a multiplication by the transpose of the matrix F, is naturally done in the favourable order for the loops. Although the dose matrices have been calculated in single precision floating point arithmetic, the algorithmic calculations have been carried out mostly in double precision in order to avoid possible effects due to small differences between large numbers or ratios between nearly identical numbers. The increase in computation time for double precision with the Pentium III Xeon architecture is a few percent at worst for the problems solved. Figure 1 shows a 9-plane U-shaped lesion with a 'spinal cord' OAR. The water-equivalent phantom consists of a 20 cm diameter cylinder in the centre of 100 × 100 voxel planes, each voxel being of dimensions 0.25 × 0.25 × 0.5 cm. The PTV and OAR regions are approximately in the centre of the cylinder. Nine equally spaced beams or ports spanning 2π were used for the optimization, each with pencil beams of 0.5 × 0.5 cm nominal cross-section at the entrance plane of the cylindrical water phantom. The dose delivered per unit fluence of each beamlet to the phantom voxels was calculated using a public domain program from the University of Wisconsin that includes all scattering terms. The calculated doses were arranged into a dose matrix containing as many columns as beamlets and as many rows as voxels are in the PTV and OAR. The number of pencil beams involved in the optimization was 1002 and the numbers of voxels were 4266 in the PTV and 1008 in the OAR. Figure 2 shows the DVHs resulting from the PTV-only optimization and the desired OAR DVH.
Cases studied
Mathematical phantom
Patient cases
The current version of the developmental software for the BrainSCAN (2001) software package has been used to generate dose matrices for patient cases in the format needed for the inversion procedures. After an optimization, the resulting beam fluences have been placed back into BrainSCAN to verify, examine and document the results. The DVHs and dose distributions shown here include the verification step in BrainSCAN, but no leaf sequencing or transmission effects have been included. Two cases will be presented here, both from UCLA, one is a brain tumour and the other is a prostate case. Figure 3 shows the central plane of a cavernous sinus meningioma adjacent to the brain stem. The defined OARs were the brain stem, the left optic nerve and the optic chiasm, the latter not visible in the plane of the figure. It is not possible to define a single entry angle that can treat the full tumour without impacting an OAR. The case was initially studied as a 14-beam conformal therapy case. An IMRS case with seven non-coplanar beams has been devised for the tests. Table 1 gives the gantry and table angles corresponding to the seven beams. The number of beamlets selected by the BrainSCAN software was 1105, of approximately 0.2 × 0.3 cm cross-section each. The numbers of voxels were 1737 in the PTV and 5383 in the OARs. After initial tests with the DPL software, a set of desired OAR DVHs was prescribed as leading to a PTV DVH that would have less than 1% of the PTV voxels receiving less than 90% dose. The DVHs resulting from a PTV-only optimization are shown in figure 4 . The points used to define the desired OAR DVHs are also shown in that figure joined by thin broken lines.
Cavernous sinus meningioma.
4.2.2.
Prostate. This case has been prepared as an example of a difficult treatment plan in which the prostate and the complete seminal vesicles are to be treated. The issues of whether the location of the vesicles can be known with sufficient precision at treatment time and/or the medical desirability for such a plan does not enter into consideration here. Figures 5(a) and (b) show two different planes of the problem, one including the prostate and the other the middle section of the vesicles. The femoral heads, the posterior wall of the bladder and the anterior wall of the rectum have been designated as OARs. Eleven coplanar beams have been specified with a single isocentre. Table 2 shows the gantry angles for the beams, with the table angle remaining at 0 degrees. The number of beams is rather high, but four of the beams have been added to a more conventional plan for the main purpose of assisting in the irradiation of the vesicles, laterally and partly through the femoral heads (beams 3, 4, 8 and 9). The addition of these four beams has brought out some interesting differences among the algorithms, as discussed in section 5.3. The number of beamlets is 4674, of approximate cross-section of 2 × 3 mm. The numbers of voxels were 1260 in the PTV and 7950 in the OARs. Figure 6 shows the results of the PTV-only optimization, along with the desired OAR DVHs shown by squares joined by broken lines. The desired DVHs for the two femoral heads are identical and so are those for the bladder and rectum walls. The principal aim was to reduce the doses in the bladder and rectum walls significantly without underdosing the PTV by more than 1 or 2% of its volume receiving less than 90% dose. No PTV volume was to receive less than 85% dose. In initial tests, the demands for low dose at the high end of OAR DVHs of figure 6 were less strict than shown in the figure. After successively becoming stricter with these demands, the desired OAR DVHs shown in the figure were arrived at as being conditions in which the different algorithms started to show differences in the optimization dose distributions.
Results
Of the many data resulting from the optimizations, the following set will be presented: When optimization results are very similar to each other, the dose distribution for only one of the results will be shown.
Results with the mathematical phantom
In order to observe the behaviour of the algorithms, it appears useful to report first the results without filtering, followed by filtered results. 
Unfiltered results.
The reported results correspond to a convergence threshold of 0.0005, except for the DPL2, where a threshold of 0.00075 was sufficient to obtain the same results as in the DPL1, and for the ASA algorithm, in which the threshold was decreased to 0.0001 in an attempt to obtain better results. The DVHs from the DPL1 and DPL2 are indistinguishable from each other and there are no substantial differences among the different algorithms, except for the ASA results. DVHs show relatively small differences from those of the filtered results, below. In all appearance, more iterations were needed for a better optimization with the ASA, but both the PTV and OAR DVHs were oscillating at the point where the algorithm stopped. Internal parameters of the ASA method were changed within a reasonable range without being able to improve the results. They were finally left with the values used in a large number of tests that have often been more successful. It appears to be in the nature of the stochastic process that sometimes it will work better than others. The dose distributions in the phantom are very similar in all the algorithms, except the ASA. For that reason, only the distributions for the DPL1 and ASA will be shown here. The beam profiles for port 0 (beamlets entering the phantom from below in figure 7 ) are shown in figure 8. The FMC is indicated to the right of each image. The grey scale is normalized to the maximum of all the profiles shown. The complex appearance of the ASA results, with higher FMC, is typical of ASA unfiltered results. The high FMC of the NG results is not due to excessive complexity in the interior of the beam maps, but to a few high beam weights in the periphery of some maps, not visible in the port shown. Table 3 gives optimization information for each of the five results. The NG-inversion time can be decreased in this problem by increasing the relaxation factor γ . One has to be careful, however, as the procedure can diverge, particularly at the later stages of the optimization, if that parameter is made too large.
Filtered results.
In inverse problems, the need for regularization or filtering is well understood. The value of the filter parameter α that gives acceptable results for clinical use has been established for the DPL to be between 0.03 and 0.05 with its internal normalizations. For the other algorithms a value of α has been selected to bring the FMC of the corresponding optimizations to approximately the same number as in the DPL, when it has been possible.
The DVHs and dose distributions for the two DPL algorithms are virtually identical and only one set of data will be shown for them. The resulting DVHs are shown in figure 9 . There has been some loss in quality with respect to the unfiltered results, as expected from filtering and the ASA results for the OAR are still noticeably worse than in the other algorithms.
The dose distribution in the central plane of the phantom is shown in figure 10 for the ASA method, which is now very similar to the distribution obtained from the other algorithms. Solid isodose lines for 35, 55, 75 and 95% are shown. The outlines of the PTV and OAR are shown in broken lines. The beam profiles for port 0 are shown in figure 11 , with the grey scale normalized to the maximum of all the profiles shown. The four non-stochastic beam profiles are quite similar to each other and the ASA profiles are substantially smoother than before filtering but still quite complex. The FMC for the NG method is substantially higher than in the other methods. Again, this is not due to lack of filtering in the interior of the beam maps, but rather to some very high beam weights in the periphery of some maps. An increase in filtering strength inside the loop would result in instability. Table 4 gives details of the optimizations.
Results with patient cases
The results with patient cases will be given for optimizations with filtering, following the guidelines discussed at the beginning of section 5.1.2. figure 12 .
There are minor but noticeable differences in the dose distributions achieved by the tested algorithms, particularly in some relatively hot-spot configurations, with the results of the NG case appearing somewhat under-filtered. The results from the DPL1 and DPL2 algorithms are virtually identical to each other and the results of all the algorithms are quite similar to each other. For that reason, only the dose distribution for the DPL1 optimization is shown in figure 13 , corresponding to the central plane of figure 3. Figures 14(a) and (b) show some relative hot spots created at a plane 33 mm superior to the central plane by the DPL and the NG algorithms. Seven isodose levels have been shown from 40 to 100%. The reasons for the existence of the hotter spot in figure 14(b) are discussed in detail in section 5.3. Figure 15 shows the fluence maps generated by the four different algorithms for Beam No. 1 in table 1, directed towards the tumour from the superior part of the cranium. The avoidance of the optic chiasm is evident in all cases. Table 5 shows the optimization data for the five methods.
It should be noted that the CG and NG methods, although they share the same cost function, reach the final results by quite different paths. The NG, in particular, emphasizes convergence of those beam weights that contribute lower dose to the target and this method has not done as well for this particular example as it did with the mathematical phantom. The ASA optimization was stopped manually because of a small oscillation in the results without further apparent improvement in the solution. The existence of some relatively hot beamlets in the periphery of the NG-beam maps has contributed to the relatively high FMC result in table 5. One of those beamlets can be seen in figure 15.
Prostate.
Less strict demands on the OAR DVHs than shown in figure 6 yielded almost identical results for all the algorithms. For the more demanding desired OAR DVHs shown in figure 6 some significant differences were observed. The resulting DVHs are shown in figure 16 . The curves for the DPL1 and DPL2 algorithms are almost identical and only those for the DPL1 have been shown. The ASA results are very close to the DPL ones. The CG results are visibly worse than those for the DPL. The CG procedure was 'stuck' at the optimization results shown, with more iterations not changing the value of the cost function in the first six significant figures. The NG results suffer from some overdosing in the PTV, not improving with more iterations. Figure 17 shows the dose distribution in the plane of figure 5(a) Figure 14 . Some hot spots shown at a plane 33 mm superior to that of figure 13 . See text for interpretation. for the ASA results and figure 18 shows the distributions in the plane of figure 5(b) for the CG method. Differences among all the algorithms at those planes are minimal. The beam maps corresponding to Beam No. 9 in table 2, one of the four beams added to facilitate the treatment of the vesicles, are shown in figure 19 . Each of the different sections is normalized to its own maximum (darkest). Optimization data are given in table 6.
The CG method shows a substantially longer optimization time than the other methods. There are two principal factors that affect inversion time in the CG method: (1) Beam weights becoming negative at the end of a line minimization step. When that happens, the weights are corrected as indicated in section 2.2 and the CG action has to be restarted. The corrected weights cannot be used to continue an ongoing calculation of conjugate gradients, as that leads to instability. Without the fast convergence of the CG, the algorithm becomes a simple The one used here is probably as fast as it can be. As discussed above, it gives an exact value x min in one single pass. The PTV-only optimization of the prostate case does not result in any beams becoming negative during most of the calculation, 40 iterations are sufficient for good convergence and they are finished in 1.0 min. The subsequent full optimization leads to negative beams immediately after starting the 115 iterations, which then take 20.11 minutes to complete. A careful analysis of the factors leading to negative beams in the CG method has been carried out. In the dynamic implementation used in the current tests and with full scattering terms in the dose matrix, it is possible to avoid negative beams only by not requiring too much from the optimization. For example, in the case of the mathematical phantom of section 4.1, requesting a maximum OAR dose of 80% and setting a second desired DVH point to 50% dose at 40% volume will lead to very fast convergence by avoiding the appearance of negative beams during the solution. The FMC for the NG algorithm is, again, higher than that of the other methods because of peripheral hot beamlets.
Hot beamlets
Beam weights with higher intensity than desired can result from an optimization (hot beamlets) and may pose a problem in the normal tissues near the entrance to the patient, or elsewhere. They occur in two distinct situations. Table 2 , a lateral port added to facilitate the irradiation of the seminal vesicles. DPL1 and DPL2 results were practically identical. Each map is normalized to its maximum. The high fluences at the bottom of the maps correspond to the upper section of the seminal vesicles.
1. At entry or exit edges of the PTV. Pencil beams that contribute to PTV dose with their penumbra may end an optimization with high weights so that that penumbra brings up the delivered dose to the PTV, and 2. When a beamlet or beamlets from a particular port have a direct view of a portion of the PTV, unobstructed by OARs, while beamlets from other ports have to pass through OARs to reach that same PTV portion.
In the first case, filtering as described above corrects the problem to a large extent, although the NG algorithm could not be filtered sufficiently inside the loop to achieve more desirable results. In the second case filtering only diminishes the high fluxes slightly because the main likelihood or cost terms of the target function dominate the solution. It is with respect to the second case that a significant difference between the DPL and the gradient-based methods has been observed. It will be shown that the DPL is a more effective parameter estimator than the other methods but this effectiveness may have to be 'degraded' for clinical use. This example corresponds to the prostate case described above, but with desired OAR DVHs that are less strict than those of figure 6. Consider figures 20(a) and (b), in which the top plane of the seminal vesicles is shown for the DPL and the NG results, respectively. This plane is 9 mm superior to the one shown in figure 18 . The intensities of the beamlets involved appear at the bottom of the maps in figure 19 , as these maps are inverted with respect to the patient's anatomy. The four lateral beams have practically taken over the irradiation of the top of the vesicles but this effect is substantially more pronounced in the DPL case than in the others. The dose near the entrance of the lower left beams in the figures is above 95% for the DPL and just above 75% for the NG method. The corresponding result for the ASA is just above 55% and barely above 75% for the CG. One can then ask the question whether the DPL result, which would be medically unacceptable, is an artifact of that algorithm or the gradient algorithms would eventually reach the same result if allowed the continue their optimizations.
In order to find an answer to that question, extended optimizations with the gradient algorithms were made to a stopping point with a convergence parameter 20 times smaller than in the original calculation. The NG algorithm had no difficulty with small gradients and reached results similar to those of the DPL (approximately 100% near the entrance to the patient). The ASA did not go very far due to fluctuations in the results of successive iterations. Decreasing the size of the test fluences allowed the algorithm to go part of the way. The CG also went a long way towards the DPL results, but the very small gradients slowed down further convergence.
What the above results indicate is that a solution with the 'hot beamlets' has a lower quadratic cost than one without them and, mathematically, is a better solution to the minimum least squares problem. Although the DPL does not minimize the quadratic cost exactly, as discussed in section 2.1, it easily finds mathematically optimum beam weights under the criterion that take a very long processing time for the quadratic cost optimizations to find.
Investigation of a more 'homogeneous' medical case has also been carried out. In that case, the PTV consists of a single tumour of roughly spherical shape in the brain, as opposed to the prostate and the vesicles that have very different and complex geometry. In that case, the gradient methods are nearly as effective in bringing up the hot beamlets as the DPL. Also, in the more demanding OAR conditions of figure 6, both the DPL and the NG algorithms exhibit similar hot beamlets.
This mathematical characteristic of the DPL may be undesirable in some cases. In the BrainSCAN (2001) software, a user can apply hard constraints to the maximum fluences allowed in any beam by limiting the beamlet values to some factor above what they would have in a conformal-therapy plan. This strategy solves the problem of hot beamlets with necessarily some loss in the quality of the resulting DVHs.
Conclusions
For the purpose of optimization in the specific conditions expressed in items 1 through 4 of the introduction, this study indicates the following.
(a) The DPL1 method works flawlessly without any adjustable algorithm-specific parameters, although there may be more of a need to constrain the beam weights to avoid 'hot beamlets' than in other algorithms. Changing the OAR weight parameters β i in a range of values from 0.1 to 10.0, the resulting OAR DVHs adhere progressively more to the desired values, with the PTV suffering from higher under-dosing in the upper left-hand section of the DVH as the OAR weights increase. (b) The DPL2 method works almost identically to the DPL1 method in approximately 60% of the optimization time. Adjustment of the acceleration exponent n needs to be understood in more detail, particularly when some OARs are assigned high weights in the optimization. As indicated above, when those values are set above approximately 5.0, the exponent n has to be reduced for stability. (c) The ASA leads to beam maps that appear more complex than those of the non-stochastic algorithms and may, therefore, be less desirable for delivery by MLCs. It may lead to non-uniform dose distributions if used unfiltered. Optimization times are rather long. Although OAR weights below 1.0 lead to lower adherence to the desired DVHs than shown in this paper, increasing those weights above 1.0 does not result in substantially higher adherence. The reason for this behaviour is not well understood at this time. (d) The CG method is slower than the other methods in large optimization cases because of the need to operate as a simple-gradient method with line minimization. It also appears that, in demanding cases, the solution may reach a point in which further iterations do not lead to an improvement of the optimization. Changing the OAR weights between 0.1 and 10 leads to the expected results, as in the DPL1 case. (e) The NG method may become cumbersome if a robust filter inside the optimization loop is desired. As indicated by Bortfeld (personal communication) , that is not a problem in the implementation of this algorithm in Heidelberg. They stratify the beam weights into five levels after the optimization and use a median filter 'a posteriori', leading to satisfactory results (Kessen et al 2000) . The observed higher values of the FMC due to the existence of hot beamlets in the periphery of the beam maps can certainly be avoided in practice by either of two methods: removal from the optimization of peripheral beamlets that deposit very little energy in the PTV voxels or use of a filter (like the median filter) after the optimization that will remove those high values from the beam maps. The NG method appears to lead to less than optimum solutions in a very demanding case. Optimization times can be relatively slow, depending on the problem. Decreasing the OAR weights below 1.0 leads to the expected results, but using values larger than 1.0 can lead to strong instability. If β i values larger than 1.0 are needed, the values of the relaxation parameter γ in equation (7) have to be reduced from those obtained by the process described in section 3.2.
It should be pointed out that the DPL1 algorithm is the only one of those tested that has assured convergence to a unique solution without having to set intermediate negative beam weights to zero during the iterative procedure. One possible disadvantage of the DPL methodology is that, perhaps in the future, cost functions other than quadratic may become important. Gradient methods will be able to handle them as long as the 'target parameter' (dose at the present time) is linear with respect to beam intensities. Biological parameters, being extremely non-linear, will have to be handled by optimization methods suitable for non-linear parameter estimation. It is not clear whether setting negative intermediate results to zero during the iterations of the gradient methods is important or not, since they can yield excellent results, but the statement can be made that, with approximately 5 to 10% of the beam weights becoming negative in the CG and NG methods in the latter part of the iterative process, the results cannot be precisely minimum least squares solutions, as the theories for those methods require the existence of negative beam weights.
Use of the DPL2 in a clinical setting will require more extensive testing and development to avoid the possibility of instability in the solution if the acceleration parameter is set too high for specific values of OAR weights. The stochastic ASA method appears to suffer when compared to the deterministic methods in that there is no way of knowing what is happening during an optimization, there are many internal parameters to adjust and one cannot predict what the result of changing them will be. The DPL method is protected by US Patent 5,602,892. A patent for the ASA method has been applied for.
It has been mentioned in the introduction that a simulated annealing algorithm based on the patent by the Nomos Corporation is basically out of contention for the purposes of this paper. In this appendix an implementation of that algorithm (NM) will be discussed briefly and some comparative results will be shown.
The NM algorithm uses the infrastructure devised for the ASA algorithm, including avoidance of over-constraining the PTV and the dynamic character of the cost function. The cost function of the NM algorithm is based on the desired DVHs: for the PTV it is a straight vertical line at 100% dose and for the OARs they are specified by the different user-supplied points, joined by straight lines. The desired DVHs are sampled in a number of vertical points and quadratic or 'absolute value' distance cost functions are generated. It has been found that the DVHs have to be formed with a relatively large number of bins and the sampling has to be frequent if best results are to be obtained. For the problems tested, DVHs with 800 bins have been used, sampled at 400 points. The quadratic cost function between the desired dose at each of the sampling points and the actual dose at the current iteration has been found to yield somewhat better results than an 'absolute value' function and it has been used. The NM formulation cannot include filtering inside the optimization loop and, therefore, its results have to be compared to unfiltered results with the other algorithms. Figure 21 shows the dose distribution obtained by the NM algorithm for the same plane of the mathematical phantom shown in figure 7(b), to which it can be compared. Optimization time was 11.38 min, compared to 0.96 min for the ASA. Figure 22 shows the dose distribution obtained by the NM algorithm for the same plane of figure 5(a) , showing no substantial differences with the corresponding results by other algorithms. The NM iterative procedure was stopped at iteration 300 although it had not reached the specified convergence point after 182.5 min of calculation. This figure can be compared to 19.65 min for the unfiltered ASA at the desired convergence point.
It must be mentioned that the computation time of the NM algorithm can be substantially lowered by decreasing the number of bins in the DVHs and sampling the DVHs less frequently. These changes result invariably in lower quality of the PTV DVHs, particularly in the underdosing part of the curve.
